ArticleJournal of gastrointestinal oncology2020

Highly expressed Claudin18.2 as a potential therapeutic target in advanced gastric signet-ring cell carcinoma (SRCC).

Bo Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.